UH professor working on anti-opioid vaccine
A $25 million grant has been awarded to a UH psychology professor to create an adjuvant opioid use disorder vaccine.
The development of the vaccine is a joint effort between Kosten, associate professor in UH College of Pharmacy, Greg Cuny and associate professor of psychology, Colin Haile. The three also partnered with vaccine scientists at the Precision Vaccines Program at Boston Children’s Hospital.
“The focus of this grant is to test various adjuvants, agents that boost the immune response, along with the anti-fentanyl vaccine that we developed, to find the vaccine/adjuvant compound that most effectively blocks the effects of fentanyl and lead to high and long-lasting antibody levels,” Kosten said.
E-Mail
BOSTON - At the start of the COVID-19 pandemic, very little was known about SARS-CoV-2, the virus that causes COVID-19. Over the past year, more evidence has become available on how the virus is transmitted, who is at the greatest risk and best practices to prevent exposure. Yet questions still remain about how the virus impacts the health of pregnant women and newborns.
In a new study published in
JAMA Network Open, physician-researchers from Beth Israel Deaconess Medical Center (BIDMC), Brigham and Women s Hospital, Boston Children s Hospital and Massachusetts General Hospital reveal that, while mother-to-newborn transmission of the virus is rare, newborns of expectant mothers with COVID-19 can suffer indirect adverse health risks as a result of worsening maternal COVID-19 illness.
First-of-its-Kind Study Found Infants of Socially Vulnerable Mothers were at Highest Risk of COVID-19 Infection
BOSTON – At the start of the COVID-19 pandemic, very little was known about SARS-CoV-2, the virus that causes COVID-19. Over the past year, more evidence has become available on how the virus is transmitted, who is at the greatest risk and best practices to prevent exposure. Yet questions still remain about how the virus impacts the health of pregnant women and newborns.
In a new study published in JAMA Network Open, physician-researchers from Beth Israel Deaconess Medical Center (BIDMC), Brigham and Women’s Hospital, Boston Children’s Hospital and Massachusetts General Hospital reveal that, while mother-to-newborn transmission of the virus is rare, newborns of expectant mothers with COVID-19 can suffer indirect adverse health risks as a result of worsening maternal COVID-19 illness.
Study reveals mother-to-newborn COVID-19 infection rates are low but indirect risks exist ANI | Updated: Apr 23, 2021 23:37 IST
Boston [US], April 23 (ANI): While mother-to-newborn transmission of the virus is rare, newborns of expectant mothers with COVID-19 can suffer indirect adverse health risks as a result of worsening maternal COVID-19 illness - suggest the findings of a new study.
The study published in JAMA Network Open was led by physician-researchers from Beth Israel Deaconess Medical Center (BIDMC), Brigham and Women s Hospital, Boston Children s Hospital and Massachusetts General Hospital. At the start of the pandemic, there was very little data to guide evidence-based newborn care practices, said corresponding author Asimenia Angelidou, MD, PhD, a neonatologist at BIDMC. We believe ours is the first study to dive into the risk factors for mother-to-newbornSARS-CoV-2 transmission. We expected the mode of delivery and/or the de
Scientists receive NIH grant to develop an adjuvant vaccine for opioid use disorder news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.